Circulating biomarkers of kidney angiomyolipoma and cysts in tuberous sclerosis complex patients.
Clinical genetics
Endocrinology
Pathophysiology
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
19 Jul 2024
19 Jul 2024
Historique:
received:
26
02
2024
revised:
04
05
2024
accepted:
11
06
2024
medline:
19
7
2024
pubmed:
19
7
2024
entrez:
19
7
2024
Statut:
epublish
Résumé
Patients with tuberous sclerosis complex (TSC) develop multi-organ disease manifestations, with kidney angiomyolipomas (AML) and cysts being one of the most common and deadly. Early and regular AML/cyst detection and monitoring are vital to lower TSC patient morbidity and mortality. However, the current standard of care involves imaging-based methods that are not designed for rapid screening, posing challenges for early detection. To identify potential diagnostic screening biomarkers of AML/cysts, we performed global untargeted metabolomics in blood samples from 283 kidney AML/cyst-positive or -negative TSC patients using mass spectrometry. We identified 7 highly sensitive chemical features, including octanoic acid, that predict kidney AML/cysts in TSC patients. Patients with elevated octanoic acid have lower levels of very long-chain fatty acids (VLCFAs), suggesting that dysregulated peroxisome activity leads to overproduction of octanoic acid via VLCFA oxidation. These data highlight AML/cysts blood biomarkers for TSC patients and offers valuable metabolic insights into the disease.
Identifiants
pubmed: 39027368
doi: 10.1016/j.isci.2024.110265
pii: S2589-0042(24)01490-1
pmc: PMC11255849
doi:
Types de publication
Journal Article
Langues
eng
Pagination
110265Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors declare no competing interests.